covid 19 News and Research

RSS

Key lessons from San Diego's Hepatitis A outbreak can be applied to COVID-19 pandemic

In an age when many people get their news from social media, ensuring health information is communicated accurately and understood clearly is critical, especially during infectious disease outbreaks.

16 Oct 2020

Objective measures reveal a higher prevalence of smell loss in COVID-19 patients

Smell loss is a frequently reported symptom of COVID-19 but reports of prevalence vary from study-to-study and range from 5% to 98%. With such a wide range of estimates, it is difficult to prioritize its importance for testing and treatment.

16 Oct 2020

LGBTQ+ campus resource centers are essential to meet the needs of LGBTQ+ students

"Essential services" is a phrase that has become commonplace in the era of COVID-19. In a new commentary piece, scholars from Lehigh University and Ohio State University argue that LGBTQ+ college and university campus resource centers are essential to the health, well-being and academic achievement of LGBTQ+ students.

16 Oct 2020

NIH launches adaptive Phase 3 clinical trial to test immune modulator drugs in COVID-19 patients

The National Institutes of Health has launched an adaptive Phase 3 clinical trial to evaluate the safety and efficacy of three immune modulator drugs in hospitalized adults with COVID-19.

16 Oct 2020

New video campaign highlights how anesthetists are ‘always ready’ on the medical frontline

More than 50 anesthetists across Australia have participated in a new video campaign that highlights how they are ‘always ready’ on the medical frontline.

16 Oct 2020

Healthcare workers experience mental health problems during and after pandemics

Mental health problems such as Post-Traumatic Stress Disorder, anxiety and depression are common among healthcare staff during and immediately after pandemics – according to new research from the University of East Anglia.

16 Oct 2020

Antibody levels drop rapidly in recovering COVID-19 patients, shows study

In the absence of approved, effective treatments for COVID-19, some hospitals have been treating patients with severe COVID symptoms with blood plasma from recovering patients.

16 Oct 2020

New diagnostic test detects and identifies SARS-CoV-2 virus in less than five minutes

Scientists from Oxford University’s Department of Physics have developed an extremely rapid diagnostic test that detects and identifies viruses in less than five minutes.

16 Oct 2020

Study: COVID-19 has prompted Americans to focus more on their health

A new study released today by digital health company Rally Health, Inc. found a significant proportion of Americans have a poor understanding of preventive care, while at the same time, COVID-19 has prompted them to focus more on their health.

16 Oct 2020

Governments must expand mental health and drug treatment services for young people

Governments must urgently expand mental health and drug treatment services before it’s too late, the Ted Noffs Foundation has said, warning that official data showing skyrocketing numbers of Victorians accessing crisis support signals the beginning of a national crisis.

16 Oct 2020

Control trial proves effectiveness of repurposed drugs for COVID-19 treatment

In just six months, the world's largest randomized control trial on COVID-19 therapeutics has generated conclusive evidence on the effectiveness of repurposed drugs for the treatment of COVID-19.

16 Oct 2020

New article explores the endemic potential of COVID-19 virus

A new article by Columbia Mailman School researchers Jeffrey Shaman and Marta Galanti explores the potential for the COVID-19 virus to become endemic, a regular feature producing recurring outbreaks in humans.

16 Oct 2020

New book highlights climate crisis, urges governments for a sustainable future

When COVID-19 announced its catastrophic presence in the global theatre it temporarily upstaged the climate crisis which showed we were on the path to environmental and social disaster.

16 Oct 2020

CRISPR-based engineered cell lines can accelerate potential treatment targets for SARS-CoV-2

Synthego, the genome engineering company, has collaborated with The Krogan Lab, a world-renowned scientific research unit at the Quantitative Biosciences Institute (QBI) at the University of California, San Francisco (UCSF), to deliver multiple CRISPR-based engineered cell lines to accelerate the study of potential treatment targets for SARS-CoV-2, the novel coronavirus that causes COVID-19 disease.

16 Oct 2020

People may be skeptical about medical and health articles on crowd-sourced websites

People may be skeptical about medical and health articles they encounter on crowdsourced websites, such as Wikipedia and Wikihealth, according to researchers.

16 Oct 2020

Impact of COVID-19 on Australians with hypertension

Ten months into the COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), it is unclear how people with hypertension are coping, given their increased risk. A retrospective case-control study compared people with hypertension to matched healthy controls during COVID-19 lockdown to determine whether they have higher risk perceptions, anxiety, and prevention intentions. The study is published on the preprint server medRxiv* in October 2020.

16 Oct 2020

Scientists discover a novel antiviral strategy for treating COVID-19

A research team led by Professor Hongzhe SUN, Norman & Cecilia Yip Professor in Bioinorganic Chemistry, Department of Chemistry, Faculty of Science, and Professor Kwok Yung YUEN, Henry Fok Professor in Infectious Diseases, Department of Microbiology, Li Ka Shing Faculty of Medicine of the University of Hong Kong (HKU), has discovered a novel antiviral strategy for treatment of COVID-19.

16 Oct 2020

Rapid development of functionally diverse SARS-COV-2 mouse monoclonal antibodies

Now, a recent study published on the preprint server bioRxiv in October 2020 reports the development of a rapid process for generating high-affinity mouse mAbs, and their functional attributes.

16 Oct 2020

Exposure to ancient parasites may be linked to humans’ response to coronavirus

Why are some people more resilient to viruses than others? The answer has eluded scientists for centuries and, in the age of COVID-19, has come to represent one of the holy grails of biomedical research.

16 Oct 2020

NFID issues new report detailing risks of co-infection with flu and COVID-19 in vulnerable adults

The National Foundation for Infectious Diseases (NFID) issued a new Call to Action report detailing the risks of co-infection with influenza (flu) and COVID-19 in adults with chronic health conditions, and the importance of flu vaccination during the 2020-2021 season.

16 Oct 2020

covid 19 News and Research

Key lessons from San Diego's Hepatitis A outbreak can be applied to COVID-19 pandemic

Objective measures reveal a higher prevalence of smell loss in COVID-19 patients

LGBTQ+ campus resource centers are essential to meet the needs of LGBTQ+ students

NIH launches adaptive Phase 3 clinical trial to test immune modulator drugs in COVID-19 patients

New video campaign highlights how anesthetists are ‘always ready’ on the medical frontline

Healthcare workers experience mental health problems during and after pandemics

Antibody levels drop rapidly in recovering COVID-19 patients, shows study

New diagnostic test detects and identifies SARS-CoV-2 virus in less than five minutes

Study: COVID-19 has prompted Americans to focus more on their health

Governments must expand mental health and drug treatment services for young people

Control trial proves effectiveness of repurposed drugs for COVID-19 treatment

New article explores the endemic potential of COVID-19 virus

New book highlights climate crisis, urges governments for a sustainable future

CRISPR-based engineered cell lines can accelerate potential treatment targets for SARS-CoV-2

People may be skeptical about medical and health articles on crowd-sourced websites

Impact of COVID-19 on Australians with hypertension

Scientists discover a novel antiviral strategy for treating COVID-19

Rapid development of functionally diverse SARS-COV-2 mouse monoclonal antibodies

Exposure to ancient parasites may be linked to humans’ response to coronavirus

NFID issues new report detailing risks of co-infection with flu and COVID-19 in vulnerable adults

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News